NSW bans reusable medical supplies, sparking clash between clinicians and industry
New South Wales’ Clinical Excellence Commission prohibited hospitals from using remanufactured medical items, prompting health workers to accuse the agency of favoring large disposable-device makers.
The NSW Clinical Excellence Commission sent a letter to the TGA urging a regulatory split between third-party remanufacturers and original manufacturers, raising concerns about intellectual-property rights and decontamination standards. Health professionals, including an anonymous staff member identified as Charlie, contend the commission’s objections are not evidence-based and that remanufactured devices are barcoded for full traceability.
Medsalv’s chief executive Oliver Hunt says the company has repeatedly tried to explain its processes, yet the commission has not engaged. Cardinal Health, which posted a US$2.6 billion profit last year, is reported to have lobbied against Medsalv’s operations and is planning its own remanufacturing plant. The dispute highlights the potential for up to $16 million a year in waste-disposal savings for NSW, equivalent to the weight of the Sydney Harbour Bridge, while raising questions about patient safety and environmental impact.
Why it matters
The outcome will affect hospital waste costs, patient safety standards, and the growth of sustainable medical device markets in Australia.
In this story
